U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06927739) titled 'Focused Orticumab Research for Treating Inflammation in Coronary Arteries' on March 25.
Brief Summary: The goal of this clinical trial is to determine the clinical effect of orticumab treatment on inflammation in study participants with prior myocardial infarction who have elevated coronary inflammation based on CCTA. The main question it aims to answer is:
Clinical effects of orticumab treatment on inflammation of the coronary artery parameters measured with CCTA
Researchers will compare the effects with placebo group after 6 months of treatment
Participants will Keep the planned study visit appointments Provide complete inform...